Skip to main content
SpringerLink
Log in

Serum Levels of Soluble TNF-α Receptor-II (P75), Circulating γδ T-Cells and Adamantiades-behçet’s Disease Activity

  • Chapter
Adamantiades-Behçet’s Disease

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 528))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Yazici, H., 1994, Behçet’s syndrome. In Rheumatology (J.H. Klippel, P.A. Dieppe, eds.), Mosby-Year Book Europe.

    Google Scholar 

  2. Sakane, T., Takeno, M., Suzuki, N., et al., 1999, Behçet’s disease. N. Engl. J. Med. 341: 1284–1291.

    Article  CAS  PubMed  Google Scholar 

  3. Direskeli, H., Eksioglu-Demiralp, E., Kibaroglu, A., et al., 1999, Oligoclonal T cell expansions in Behçet’s disease. Clin. Exp. Immunol. 117: 166–170

    Google Scholar 

  4. Yamashita, N., Kaneoka, H., Kaneko, S., et al., 1997, Role of γδ T lymphocytes in the development of Behçet’s disease. Clin. Exp. Immunol. 107: 241–247.

    Article  CAS  PubMed  Google Scholar 

  5. Hart, P.H., Hunt E.K., Bonder, C.S., et al., 1996, Regulation of surface and soluble TNF receptor expression on human monocytes and synovial fluid macrophage by IL-4 and IL-10. J. Immunol. 157: 3672–3680.

    CAS  PubMed  Google Scholar 

  6. Cope, A.P., and Maini, R.N., 1995, Soluble TNF receptors in arthritis. J. Rheumatol. 22: 382–384.

    CAS  PubMed  Google Scholar 

  7. Weckmann, A.L., and Alcocer-Verela, J., 1996, Cytokine inhibitors in autoimmune disease. Semin. Arthritis Rheum. 26: 539–557.

    Article  CAS  PubMed  Google Scholar 

  8. Sayinalp, N., Ozcebe, O.I., Ozdemir, O., et al., 1996, Cytokines in Behçet’s disease. J. Rheumatol. 23: 321–322.

    CAS  PubMed  Google Scholar 

  9. Turan, B., Gallati, H., Erdi, H., et al., 1997, Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Behçet’s disease; soluble TNFR-75 as a biological marker of disease activity. J. Rheumatol. 24: 128–132.

    CAS  PubMed  Google Scholar 

  10. International Study Group for Behçet’s Disease, 1990, Criteria for diagnosis of Behçet’s Disease. Lancet 335: 1078–1080.

    Google Scholar 

  11. Sfikakis, P.P., Theodosiades, P.G., Katsiari, C.G., et al., 2001, Effect of infliximab on sight-threatening panuveitis in Behçet’s disease. Lancet 358: 295–296.

    Article  CAS  PubMed  Google Scholar 

  12. Katsiari, C.G., Liossis, S.-N.C., Souliotis, V.L., et al., 2002, Aberrant expression of the costimulatory molecule CD40L on monocytes from patients with systemic lupus erythematosus. Clin. Immunol. 103: 54–62.

    Article  CAS  PubMed  Google Scholar 

  13. Gabay, C., Cakir, N., Moral, F., et al., 1997, Circulating levels of TNF soluble receptors in SLE are significantly higher than in other rheumatic diseases and correlate with disease activity. J. Rheumatol. 24: 303–308.

    CAS  PubMed  Google Scholar 

  14. Heilig, B., Fiehn, C., Brockhaus, M., et al., 1993, Evaluation of soluble TNF receptors in patients with SLE, PSS and MCTD. J. Clin. Immunol. 13: 321–328.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Immunology Department, Evagelismos Hospital, Athens, Greece

    Violeta Kapsimali

  2. First Dept of Propedeutic Medicine Laikon Hospital, Athens University Medical School, Athens, Greece

    Antonia V. Elezoglou & Peter P. Sfikakis

  3. First Department of Medicine, Laikon Hospital, Athens University Medical School, Athens, Greece

    George Vaiopoulos & Phaedon G. Kaklamanis

Authors
  1. Antonia V. Elezoglou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter P. Sfikakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. George Vaiopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Violeta Kapsimali
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Phaedon G. Kaklamanis
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University Medical Center Benjamin Franklin, The Free University of Berlin, Berlin, Germany

    Christos C. Zouboulis

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Kluwer Academic Publishers

About this chapter

Cite this chapter

Elezoglou, A.V., Sfikakis, P.P., Vaiopoulos, G., Kapsimali, V., Kaklamanis, P.G. (2004). Serum Levels of Soluble TNF-α Receptor-II (P75), Circulating γδ T-Cells and Adamantiades-behçet’s Disease Activity. In: Zouboulis, C.C. (eds) Adamantiades-Behçet’s Disease. Advances in Experimental Medicine and Biology, vol 528. Springer, Boston, MA. https://doi.org/10.1007/0-306-48382-3_52

Download citation

  • DOI: https://doi.org/10.1007/0-306-48382-3_52

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-47757-7

  • Online ISBN: 978-0-306-48382-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation